Clinical Trials
5
Active:0
Completed:4
Trial Phases
3 Phases
Phase 2:2
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Not Applicable
1 (25.0%)Phase 3
1 (25.0%)Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
Phase 3
Recruiting
- Conditions
- Iron Deficiency Anemia
- Interventions
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 104
- Registration Number
- NCT04268849
- Locations
- 🇺🇸
Auerbach Hematology and Oncology, Baltimore, Maryland, United States
Iron Parameters in Non-anemic First Trimester Gravidas
Completed
- Conditions
- Iron Deficiency (Without Anemia)Pregnancy
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 102
- Registration Number
- NCT03670537
- Locations
- 🇺🇸
Auerbach Hematology and Oncology, Baltimore, Maryland, United States
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
Phase 2
Completed
- Conditions
- Restless Legs SyndromeIron Deficiency Anemia
- Interventions
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 100
- Registration Number
- NCT02499354
- Locations
- 🇺🇸
Auerbach Hematology Oncology Assoc, Baltimore, Maryland, United States
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
Phase 2
Completed
- Conditions
- Pregnancy
- Interventions
- Drug: Intravaneous iron(low molecular weight iron dextran)
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2018-06-28
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 74
- Registration Number
- NCT02038023
- Locations
- 🇺🇸
Auerbach Hematology Oncology Assoc, Baltimore, Maryland, United States
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 60
- Registration Number
- NCT01374919
- Locations
- 🇺🇸
Auerbach Hematology and Oncology, Baltimore, Maryland, United States
News
No news found